These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3458695)

  • 1. Pefloxacin--a laboratory and clinical evaluation of a new quinolone. Based on papers presented at the 14th International Congress of Chemotherapy. Kyoto, Japan, June 1985.
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-118. PubMed ID: 3458695
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
    Periti P; Mazzei T; Nicoletti P
    Chemioterapia; 1987 Apr; 6(2):75-8. PubMed ID: 3474081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of pefloxacin against gram-negative and gram-positive bacteria in comparison with other antibiotics.
    Debbia E; Schito GC; Nicoletti G; Speciale A
    Chemioterapia; 1987 Oct; 6(5):319-23. PubMed ID: 3480779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Initial antibiotherapy in severe bacterial bronchopneumopathies. Randomized study of a new quinolone: pefloxacin].
    Fourrier F; Chopin C; Lestavel P; Savage C
    Presse Med; 1986 Jun; 15(26):1240. PubMed ID: 2944094
    [No Abstract]   [Full Text] [Related]  

  • 5. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
    Husson MO; Izard D; Bryskier A; Leclerc H
    Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of pefloxacin in the treatment of severe infections in patients hospitalized in intensive care units.
    Lauwers S; Vincken W; Naessens A; Pierard D
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():111-5. PubMed ID: 3458696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of subinhibitory concentrations of pefloxacin on the adherence of Staphylococcus aureus to human cells.
    Desnottes JF; Diallo N; Moret G; Santonja R
    Drugs Exp Clin Res; 1987; 13(2):69-73. PubMed ID: 3472868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro activity of pefloxacin in combination with other antimicrobial agents.
    Manek N; Wise R; Andrews J
    J Antimicrob Chemother; 1986 Jun; 17(6):827-8. PubMed ID: 3460985
    [No Abstract]   [Full Text] [Related]  

  • 9. Quinolone antimicrobial agents in acute exacerbations of chronic bronchitis.
    Maesen FP; Davies BI; Teengs JP; Baur C
    Eur J Respir Dis Suppl; 1986; 146():585-90. PubMed ID: 3465584
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pefloxacine and severe eye infections].
    Massin-Cochereau I; Le Hoang P; Weiser M; Rousselie F
    Bull Soc Ophtalmol Fr; 1987; 87(6-7):735-6, 738. PubMed ID: 3499243
    [No Abstract]   [Full Text] [Related]  

  • 11. Pefloxacin: evolution of in vitro activity during 18 months of use in an intensive care unit.
    Tigaud S; Marcatello A; Gille Y; Robert D; Vincent P
    Drugs Exp Clin Res; 1985; 11(3):169-76. PubMed ID: 3869804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pefloxacin: clinical experience].
    Bertrand A; Janbon F; Jourdan J; Jonquet O; Santoni A
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):596-9. PubMed ID: 3937133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pefloxacin: evaluation and clinical prospects].
    Modaï J
    Rev Med Interne; 1986 Mar; 7(2):205-10. PubMed ID: 3459223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic contribution of the new quinolones].
    Wolff M
    Rev Prat; 1987 Apr; 37(21):1209-14. PubMed ID: 3474759
    [No Abstract]   [Full Text] [Related]  

  • 15. Pefloxacin in the treatment of lower respiratory tract infections in geriatrics.
    Vanderdonckt J
    J Int Med Res; 1987; 15(4):234-9. PubMed ID: 3477513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro action of fosfomycin combined with rifampicin, pefloxacin and imipenem on staphylococci (checkerboard method in a liquid medium)].
    Quentin C; Noury P; Laurent C; Saivin S; Bebear C
    Pathol Biol (Paris); 1987 Feb; 35(2):153-7. PubMed ID: 3550623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of pefloxacin.
    Husson MO; Izard D; Bouillet L; Leclerc H
    Drugs Exp Clin Res; 1986; 12(4):313-7. PubMed ID: 3522154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of pefloxacin compared to that of quinolones and other antimicrobial agents.
    Neu HC; Chin NX; Labthavikul P; Saha G
    Chemioterapia; 1984 Aug; 3(4):235-41. PubMed ID: 6241847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance in anaerobic bacteria. Based on a symposium held at the 12th International Congress of Chemotherapy Florence, 22 July 1981.
    J Antimicrob Chemother; 1981 Dec; 8 Suppl D():1-132. PubMed ID: 7338484
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of pefloxacin activity against recent clinical isolates.
    Lembo M; Covelli B; Nani E; Lavitola A
    J Chemother; 1991 Jan; 3 Suppl 1():51-3. PubMed ID: 12041785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.